-transparent.png){kind=logo}
This paper reports a randomized, controlled, partially-blinded, flexible dose, parallel group, comparative study of the efficacy and tolerance of pipothiazine palmitate and fluphenazine decanoate in patients in remission from Schizophrenia over a 28 week period. The results show that pipothiazine palmitate is at least as efficacious and well-tolerated as fluphenazine decanoate in preventing relapses from maintained Schizophrenia.
Related Publications
O K Leong, and
K E Wong, and
W K Tay, and
R C Gill
May 1976,
The New Zealand medical journal,
O K Leong, and
K E Wong, and
W K Tay, and
R C Gill
October 1975,
Current therapeutic research, clinical and experimental,
O K Leong, and
K E Wong, and
W K Tay, and
R C Gill
January 1977,
International pharmacopsychiatry,
O K Leong, and
K E Wong, and
W K Tay, and
R C Gill
January 1987,
Progress in neuro-psychopharmacology & biological psychiatry,
O K Leong, and
K E Wong, and
W K Tay, and
R C Gill
December 1979,
Psychiatry research,
O K Leong, and
K E Wong, and
W K Tay, and
R C Gill
October 1986,
Ceskoslovenska psychiatrie,
O K Leong, and
K E Wong, and
W K Tay, and
R C Gill
December 1985,
Singapore medical journal,
O K Leong, and
K E Wong, and
W K Tay, and
R C Gill
January 1988,
Psychopharmacology,
O K Leong, and
K E Wong, and
W K Tay, and
R C Gill
January 1975,
Current medical research and opinion,
O K Leong, and
K E Wong, and
W K Tay, and
R C Gill
July 1981,
Indian journal of psychiatry,
